Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mori, M.
Right arrow Articles by Hattori, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mori, M.
Right arrow Articles by Hattori, T.
Neurology 2001;56:1104-1106
© 2001 American Academy of Neurology
Brief Communications

Clinical features and prognosis of Miller Fisher syndrome

Masahiro Mori, MD;, Satoshi Kuwabara, MD;, Toshio Fukutake, MD;, Nobuhiro Yuki, MD, PhD; and Takamichi Hattori, MD

From the Department of Neurology (Drs. Mori, Kuwabara, Fukutake, and Hattori), Chiba University School of Medicine, Chiba, Japan; and Department of Neurology (Dr. Yuki), Dokkyo University School of Medicine, Tochigi, Japan.

Address correspondence and reprint requests to Dr. Masahiro Mori, Department of Neurology, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670 Japan; e-mail morim{at}olive.ocn.ne.jp

The authors reviewed the clinical features and outcome of Miller Fisher syndrome (MFS) for 50 consecutive patients with MFS including 28 patients who received no immunotherapy. Besides the characteristic clinical triad (ophthalmoplegia, ataxia, and areflexia), pupillary abnormalities, blepharoptosis, and facial palsy are frequent in MFS, whereas sensory loss is unusual despite the presence of profound ataxia. Patients with MFS usually had good recovery and no residual deficits.




This article has been cited by other articles:


Home page
 ChestHome page
W. Kittisupamongkol
Miller-Fisher Variant of Guillain-Barre Syndrome
Chest, July 1, 2009; 136(1): 325 - 325.
[Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
K Funakoshi, S Kuwabara, M Odaka, K Hirata, and N Yuki
Clinical predictors of mechanical ventilation in Fisher/Guillain-Barre overlap syndrome
J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 60 - 64.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M Kanzaki, K Kaida, M Ueda, D Morita, M Hirakawa, K Motoyoshi, K Kamakura, and S Kusunoki
Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1148 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S-H Lee, G-H Lim, J. S. Kim, S-Y Oh, J. K. Kim, J-K Cha, C-H Yun, J. K. Kang, H. Lee, H-K Song, et al.
Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody
Neurology, August 5, 2008; 71(6): 426 - 429.
[Abstract] [Full Text] [PDF]

Home page
 JAOA: Journal of the American Osteopathic AssociationHome page
M. P. Kozminski
Miller Fisher Variant of Guillain-Barre Syndrome: A Report of Case
J Am Osteopath Assoc, February 1, 2008; 108(2): 51 - 52.
[Full Text] [PDF]

Home page
 NeurologyHome page
M. Mori, S. Kuwabara, T. Fukutake, and T. Hattori
Intravenous immunoglobulin therapy for Miller Fisher syndrome
Neurology, April 3, 2007; 68(14): 1144 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. R. Keane
Bilateral Ocular Paralysis: Analysis of 31 Inpatients
Arch Neurol, February 1, 2007; 64(2): 178 - 180.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Kimoto, M. Koga, M. Odaka, K. Hirata, M. Takahashi, J. Li, M. Gilbert, and N. Yuki
Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies
Neurology, November 28, 2006; 67(10): 1837 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
H.-f. Li, Y.-c. Xie, and N. Inoue
Posterior Column Involvement in Miller Fisher Syndrome or Dorsal Root Ganglion Neuronopathy?
AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1881 - 1882.
[Full Text] [PDF]

Home page
 J Intensive Care MedHome page
N. Natarajan and R. Weinstein
Therapeutic Apheresis in Neurology Critical Care
J Intensive Care Med, July 1, 2005; 20(4): 212 - 225.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
L P Bennetto and P Lyons
Miller Fisher syndrome associated with Pasteurella multocida infection
J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1786 - 1787.
[Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
N. Inoue, H. Ichimura, S. Goto, Y. Hashimoto, and Y. Ushio
MR Imaging Findings of Spinal Posterior Column Involvement in a Case of Miller Fisher Syndrome
AJNR Am. J. Neuroradiol., April 1, 2004; 25(4): 645 - 648.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
M. M. Ryan and E. C. Engle
Topical Review: Acute Ataxia in Childhood
J Child Neurol, May 1, 2003; 18(5): 309 - 316.
[Abstract] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M Mori, S Kuwabara, T Fukutake, and T Hattori
Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases
J. Neurol. Neurosurg. Psychiatry, May 1, 2002; 72(5): 680 - 680.
[Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
M. Truedsson, B. Ohlsson, and K. Sjoberg
WERNICKE'S ENCEPHALOPATHY PRESENTING WITH SEVERE DYSPHAGIA: A CASE REPORT
Alcohol Alcohol., May 1, 2002; 37(3): 295 - 296.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. A. Garcia-Rivera, T.D. Rozen, D. Zhou, P. Allahyari, R. Niknam, D. Dougherty, J. Morgan, and A. Flanders
Miller Fisher syndrome: MRI findings
Neurology, November 27, 2001; 57(10): 1755 - 1755.
[Full Text] [PDF]